[1]
P. Üstün and E. Adışen, “Factors Influencing Relapse After Omalizumab in Chronic Urticaria. Does the Method of Discontinuation Influence Relapse?”, Dermatol Pract Concept, vol. 15, no. 3, p. 5196, Jul. 2025, doi: 10.5826/dpc.1503a5196.